Key result
Combination therapy with biologic agents in rheumatoid arthritis offers potential clinical benefits but is accompanied by significant risks.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Joel M. Kremer (1998) studied this question. Combination therapy with biologic agents in rheumatoid arthritis offers potential clinical benefits but is accompanied by significant risks.
Synapse has enriched 10 related papers. Consider them for comparative context: